Fridays and Zepbound: Branded vs Compounded Tirzepatide Review

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

This piece is independent editorial coverage. PlexusDx has no commercial relationship with Fridays or its parent company, and it contains no affiliate links and no compensated placements.

Full head-to-head: PlexusDx vs Fridays →

A "Fridays Zepbound" search is really a tirzepatide question in brand-name clothing. Zepbound is a branded, FDA-approved tirzepatide product, so the practical issue is how a telehealth program like Fridays sources the tirzepatide molecule. Written as balanced context rather than a purchase steer. As of April 2026.

Where Zepbound fits in the Fridays model

Zepbound is FDA-approved branded tirzepatide. Fridays (Fridays Health) is a telehealth-plus-compounded-pharmacy operation, meaning a tirzepatide prescription can be routed to a retail pharmacy for an FDA-approved brand or to a 503A compounding pharmacy for a compounded preparation. Whether a specific branded product is supplied is answered on Fridays's official website.

Reading the model correctly

The evaluation, prescription, fulfillment, and follow-up steps are consistent across telehealth GLP-1 brands. What differs is provider type, pharmacy partner, and subscription structure — and, importantly here, whether the tirzepatide is a branded product or a 503A compounded one.

Zepbound, Mounjaro, and the tirzepatide molecule

Zepbound and Mounjaro are both branded presentations of tirzepatide, differing by approved indication rather than active molecule. Tirzepatide is a GIP/GLP-1 dual agonist, engaging two incretin receptors, which sets it apart from single-receptor agonists like semaglutide. Its record includes the SURMOUNT weight-management program (NEJM, 2022) and SURMOUNT-OSA for obstructive sleep apnea (NEJM, 2024). Trial populations and endpoints vary, and outcomes are individual.

Branded Zepbound vs compounded tirzepatide options

Branded Zepbound is a manufactured, FDA-approved tirzepatide product dispensed at retail pharmacies. Compounded tirzepatide is prepared by a 503A pharmacy against an individual prescription and is not an FDA-approved product; the two are not interchangeable. A clinician decides which route is appropriate, and Fridays states its own sourcing on its pages.

Reading Fridays pricing next to Zepbound

Fridays advertises rates for its own compounded offerings, not for branded Zepbound. As of its pricing page (joinfridays.com/pricing, verified 2026-07-20), Fridays advertises compounded tirzepatide at $359/mo month-to-month, with $0 membership, free shipping, and included coaching and dietitian support; a paid-annually plan works out to roughly $240/mo. Fridays' rates moved materially within a single day. PlexusDx's month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, while Fridays' prepaid 3- and 6-month bundles can undercut PlexusDx per month. Branded Zepbound pricing is set separately by its manufacturer and pharmacy. Confirm current figures at Fridays's official website.

The pathway data a Zepbound prescription can't see

Whether the tirzepatide you receive is branded Zepbound or a compounded formulation, the prescription does not characterize your metabolic baseline. Variants in GLP1R (a GLP-1 receptor gene), FTO (the fat-mass and obesity-associated gene), MC4R (a satiety receptor), and TCF7L2 (tied to glucose homeostasis and incretin signaling) map that terrain. They are pathway-level markers — they do not predict Zepbound or tirzepatide response, but they describe the biology being prescribed into.

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including GLP1R, FTO, MC4R, and TCF7L2 variants that shape appetite and energy-balance biology. Reviewing that first is the test before you invest approach: an informed conversation with your provider instead of guesswork.

How PlexusDx frames the tirzepatide decision

PlexusDx offers tirzepatide and semaglutide through its Weight Management Protocols — including Tirzepatide Injection and Tirzepatide Oral, plus Semaglutide Injection and Semaglutide Oral. Genetic context is the piece a branded or compounded tirzepatide script rarely provides.

Not affiliated: PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: Zepbound vs Retatrutide, Zepbound vs Trulicity, Zepbound For Hypertension, Zepbound Subscription.

Disclaimer: This article is educational. PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions

Does Fridays dispense branded Zepbound?

Fridays uses a telehealth-plus-compounded-pharmacy model, so a tirzepatide prescription may route to a retail pharmacy for an FDA-approved brand or to a 503A pharmacy for compounded tirzepatide. Whether the exact branded Zepbound product is supplied is disclosed on the brand's own site; confirm before assuming.

Are Zepbound and Mounjaro the same drug?

Both are branded FDA-approved presentations of tirzepatide and share the same active molecule; they differ by approved indication. Compounded tirzepatide is a separate, non-FDA-approved preparation made by a 503A pharmacy. A clinician determines which formulation is appropriate for a given patient.

Can a genetic test predict my Zepbound results?

No. The Precision Peptide Genetic Test does not predict response to Zepbound or tirzepatide. It analyzes pathway-level variants in GLP1R, FTO, MC4R, and TCF7L2 that describe baseline incretin and energy-balance biology — context that applies whether the tirzepatide dispensed is branded or compounded.

How does PlexusDx compare to a Zepbound-style program?

PlexusDx offers tirzepatide through its Weight Management Protocols with the Precision Peptide Genetic Test for genetic context. Its month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, though prepaid bundles can undercut it per month. The differentiator is pathway-level insight.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.